Brief: Io Biotech Announces First Patient Dosed In Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
21/12/2023 14:48
Dec 21 (Reuters) - IO Biotech Inc IOBT.O :
* IO BIOTECH ANNOUNCES FIRST PATIENT DOSED IN PHASE 2
NEOADJUVANT/ADJUVANT SOLID TUMOR BASKET TRIAL
Source text for Eikon: ID:nGNX2smFXv
Further company coverage: IOBT.O
((Reuters.Briefs@thomsonreuters.com;))